skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Simple Search

Results 1 - 20 of 96  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial
Material Type:
Article 		Add to My Research

Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial

Arthritis research & therapy, 2019-04, Vol.21 (1), p.101-101, Article 101 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1879-x ;PMID: 30999929

Full text available

Citations Cited by
2
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
Material Type:
Article 		Add to My Research

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

Arthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361

Full text available

Citations Cited by
3
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
Material Type:
Article 		Add to My Research

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study

Journal of the American Heart Association, 2017-11, Vol.6 (11), p.n/a [Peer Reviewed Journal]

2017 The Authors and Takeda Pharmaceuticals. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.117.006683 ;PMID: 29102979

Full text available

Citations Cited by
4
CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
Material Type:
Article 		Add to My Research

CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES

The American heart journal, 2012-07, Vol.164 (1), p.14-20 [Peer Reviewed Journal]

Mosby, Inc. ;2012 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2012 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2012 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2012.04.011 ;PMID: 22795277 ;CODEN: AHJOA2

Full text available

Citations Cited by
5
Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
Material Type:
Article 		Add to My Research

Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials

Clinical therapeutics, 2010-12, Vol.32 (14), p.2386-2397 [Peer Reviewed Journal]

2010 ;2015 INIST-CNRS ;Copyright © 2010. Published by EM Inc USA. ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2011.01.008 ;PMID: 21353107

Full text available

Citations Cited by
6
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Material Type:
Article 		Add to My Research

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age

BMC geriatrics, 2012-03, Vol.12 (1), p.11-11, Article 11 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;2012 Jackson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Jackson et al; licensee BioMed Central Ltd. 2012 Jackson et al; licensee BioMed Central Ltd. ;ISSN: 1471-2318 ;EISSN: 1471-2318 ;DOI: 10.1186/1471-2318-12-11 ;PMID: 22436129

Full text available

Citations Cited by
7
Achieving Your Doctorate While Working in Higher Education
Achieving Your Doctorate While Working in Higher Education
Material Type:
Book 		Add to My Research

Achieving Your Doctorate While Working in Higher Education

ISBN: 9781526499127 ;ISBN: 1526499126 ;EISBN: 1529760607 ;EISBN: 9781529760606 ;EISBN: 1529760615 ;EISBN: 9781529760613

Full text available

Citations Cited by
8
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

Citations Cited by
9
Impact of Febuxostat on Renal Function in Gout Patients With Moderate‐to‐Severe Renal Impairment
Impact of Febuxostat on Renal Function in Gout Patients With Moderate‐to‐Severe Renal Impairment
Material Type:
Article 		Add to My Research

Impact of Febuxostat on Renal Function in Gout Patients With Moderate‐to‐Severe Renal Impairment

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2035-2043 [Peer Reviewed Journal]

2016, American College of Rheumatology ;2016, American College of Rheumatology. ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39654 ;PMID: 26894653

Full text available

Citations Cited by
10
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections
Material Type:
Article 		Add to My Research

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections

Clinical therapeutics, 2002-07, Vol.24 (7), p.1134-1147 [Peer Reviewed Journal]

2002 ;2002 INIST-CNRS ;Copyright Elsevier Limited Jul 2002 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/S0149-2918(02)80024-8 ;PMID: 12182257

Full text available

Citations Cited by
11
PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS
PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS
Material Type:
Article 		Add to My Research

PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS

The American journal of gastroenterology, 2022-07, Vol.117 (7), p.1158-1161 [Peer Reviewed Journal]

Copyright © 2022 by The American College of Gastroenterology. ;Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a "work of the United States Government" for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government. ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000001735 ;PMID: 35294415

Full text available

Citations Cited by
12
A Look at Cuban Schools: What Is Cuba Doing Right?
A Look at Cuban Schools: What Is Cuba Doing Right?
Material Type:
Article 		Add to My Research

A Look at Cuban Schools: What Is Cuba Doing Right?

Phi Delta Kappan, 2003-11, Vol.85 (3), p.246-249

Copyright 2003 Phi Delta Kappa International, Inc. ;2003 Phi Delta Kappa ;Copyright Phi Delta Kappa Nov 2003 ;ISSN: 0031-7217 ;EISSN: 1940-6487 ;DOI: 10.1177/003172170308500317

Full text available

Citations Cited by
13
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe
Material Type:
Article 		Add to My Research

Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.269-275 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology 2022 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000002045 ;PMID: 36191284

Full text available

Citations Cited by
14
Response to Graham
Response to Graham
Material Type:
Article 		Add to My Research

Response to Graham

The American journal of gastroenterology, 2022-11, Vol.117 (11), p.1882-1883 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000002009

Full text available

Citations Cited by
15
S390 Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial
S390 Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial
Material Type:
Article 		Add to My Research

S390 Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e272-e273 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000858200.17525.4a

Full text available

Citations Cited by
16
Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents
Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents
Material Type:
Article 		Add to My Research

Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents

Digestive diseases and sciences, 2019-02, Vol.64 (2), p.493-502 [Peer Reviewed Journal]

The Author(s) 2018 ;COPYRIGHT 2019 Springer ;ISSN: 0163-2116 ;EISSN: 1573-2568 ;DOI: 10.1007/s10620-018-5325-8 ;PMID: 30390234

Full text available

Citations Cited by
17
S1382 Vonoprazan Dual and Triple Therapy for Helicobacter pylori Eradication
S1382 Vonoprazan Dual and Triple Therapy for Helicobacter pylori Eradication
Material Type:
Article 		Add to My Research

S1382 Vonoprazan Dual and Triple Therapy for Helicobacter pylori Eradication

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S634-S634 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000779060.18666.73

Full text available

Citations Cited by
18
S1449 Helicobacter pylori Resistance Rates in the U.S. and Europe: Data From the PHALCON-HP Study
S1449 Helicobacter pylori Resistance Rates in the U.S. and Europe: Data From the PHALCON-HP Study
Material Type:
Article 		Add to My Research

S1449 Helicobacter pylori Resistance Rates in the U.S. and Europe: Data From the PHALCON-HP Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S665-S665 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000779328.88974.ad

Full text available

Citations Cited by
19
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor biologic therapy: a randomized, controlled trial
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor biologic therapy: a randomized, controlled trial
Material Type:
Article 		Add to My Research

Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor biologic therapy: a randomized, controlled trial

Arthritis research & therapy, 2019-04, Vol.21 (1) [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1879-x

Full text available

Citations Cited by
20
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
Material Type:
Article 		Add to My Research

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease

Digestive diseases and sciences, 2017-11, Vol.62 (11), p.3059-3068 [Peer Reviewed Journal]

The Author(s) 2017 ;COPYRIGHT 2017 Springer ;Digestive Diseases and Sciences is a copyright of Springer, 2017. ;ISSN: 0163-2116 ;EISSN: 1573-2568 ;DOI: 10.1007/s10620-017-4743-3 ;PMID: 28916953

Full text available

Citations Cited by

Results 1 - 20 of 96  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (50)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1978  (16)
  2. 1978 To 1989  (18)
  3. 1990 To 2006  (17)
  4. 2007 To 2016  (20)
  5. After 2016  (25)
  6. More options open sub menu

Language 

  1. English  (93)
  2. German  (3)
  3. Japanese  (3)
  4. French  (1)
  5. Spanish  (1)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait